2024 US Hospital Infectious Disease Market for 100 Tests: Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Emerging Technologies, Instrumentation and Opportunities
This new report from LeadingMarketResearch.com contains 997 pages, 87 tables, and presents a comprehensive analysis of the US hospital infectious disease testing market, including:
Introduction
Worldwide Market and Technology Overview
A. Major Infectious Disease Tests
1. AIDS
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
2. ADENOVIRUS
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
d. Adeno-Associated Viruses(AAV)
3. AEROMONAS
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
4. ANTHRAX/BACILLUS ANTHRACIS
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
5. ARBOVIRUSES
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
6. BABESIOSIS
a. Background
7. BACILLARY EPITHELIOID ANGIOMATOSIS (BEA)
And Other Bartonella (Rochalimaea)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
8. BLASTOCYSTIS HOMINIS
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
9. BRUCELLA
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
10. CAMPYLOBACTER
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
11. CANDIDA
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
12. CHAGAS DISEASE
a. Background
13. CHANCROID
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
14. CHLAMYDIA
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
15. CLOSTRIDIUM DIFFICILE
a. Background
b. Diagnostic Tests
c. Drugs and Vaccines
16. CORONAVIRUSES
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
17. COXSACKIEVIRUSES
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
18. CREUTZFELDT-JAKOB’S DISEASE
a. Background
b. Diagnostic Tests
c. Vaccines
Worldwide Market and Technology Overview
A. Major Infectious Disease Tests
1. AIDS
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
2. ADENOVIRUS
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
d. Adeno-Associated Viruses(AAV)
3. AEROMONAS
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
4. ANTHRAX/BACILLUS ANTHRACIS
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
5. ARBOVIRUSES
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
6. BABESIOSIS
a. Background
7. BACILLARY EPITHELIOID ANGIOMATOSIS (BEA)
And Other Bartonella (Rochalimaea)
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
8. BLASTOCYSTIS HOMINIS
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
9. BRUCELLA
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
10. CAMPYLOBACTER
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
11. CANDIDA
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
12. CHAGAS DISEASE
a. Background
13. CHANCROID
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
14. CHLAMYDIA
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
15. CLOSTRIDIUM DIFFICILE
a. Background
b. Diagnostic Tests
c. Drugs and Vaccines
16. CORONAVIRUSES
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
17. COXSACKIEVIRUSES
a. Background
b. Diagnostic Tests
c. Vaccines and Drugs
18. CREUTZFELDT-JAKOB’S DISEASE
a. Background
b. Diagnostic Tests
c. Vaccines
More Publications
2017-2021 US Molecular Diagnostics and NAT Market: Supplier Shares and Market Segment Forecasts
US$ 1,480.00
December 2016
-
U.S. Infectious Disease Testing Market 2021: Supplier Shares and Strategies, Test Volume and Sales Segment Forecasts, Technology and Instrumentation Review
US$ 8,865.00
May 2017
1037 pages
2015 Strategies in the US Enteric Diseases Diagnostic Testing Market
US$ 3,080.00
May 2015
322 pages